The purpose of this study is to obtain blood samples, before and after receiving a meningococcal vaccine. These samples will be used for maintaining the quality of blood tests that are used to support the development of new vaccines. The vaccinations administered in this study have already been approved and are currently available for use in Australia.
Participants will be paid for their time.
This clinical study is ongoing, the next start date is:
Saturday 22nd December
If you are unable to attend any of the dates above but are interested in participating in the study, please register below or contact us on 1800 243 733. We will have more date options throughout the year.